Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
59 hedge funds and large institutions have $49.3M invested in Applied Genetic Technologies Corporation in 2020 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 13 closing their positions.
1,001% more call options, than puts
Call options by funds: $859K | Put options by funds: $78K
156% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 9
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
30% more capital invested
Capital invested by funds: $37.9M → $49.3M (+$11.4M)
13% more funds holding
Funds holding: 52 → 59 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$5.6M |
| 2 |
Millennium Management
New York
|
+$4.34M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$4.22M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.09M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$3.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$366K |
| 2 |
JP Morgan Chase
New York
|
-$339K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$323K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$202K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$146K |
AGTC Hedge Fund Activity: Q1 2020 in Review
59 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q1 2020, worth a combined $49.3M — up 30% from $37.9M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new AGTC positions and 13 closed out — a net gain of 7 holders — while 23 added to existing stakes and 9 trimmed.
The largest buyer was Sofinnova Investments, opening a new position worth an estimated $5.6M. The largest seller was Marshall Wace, exiting entirely with an estimated $366K sold.
- 59 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q1 2020, up from 52 in Q4 2019.
- Funds reported $49.3M of Applied Genetic Technologies Corporation stock for Q1 2020, up 30% quarter-over-quarter.
- 20 funds opened new Applied Genetic Technologies Corporation positions in Q1 2020 and 13 closed out, a net change of +7 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q1 2020 was Sofinnova Investments, an estimated $5.6M added.
- The largest Applied Genetic Technologies Corporation seller in Q1 2020 was Marshall Wace, an estimated $366K sold.
Based on aggregated 13F filings for Q1 2020.